Roadshow
Ti-LUNG™ DS
For lung analysis, the Ti-LUNG™ DS Lung AI system automatically detects lung nodules, providing crucial information such as size, volume, risk of malignancy, and Lung-RADS classification.
This system also integrates coronary artery calcification analysis, aiding in the early detection of both lung cancer and cardiovascular diseases.
- Established 2013
- Company TaiHao Medical Inc.
- Telephone +886-2-2736-5679
- Email sales@taihaomed.com
- Address 6F-1, No. 100, Sec. 2, Heping E. Rd., Da’an Dist., Taipei City 106633, Taiwan (R.O.C.)
TaiHao Medical Inc., founded in 2013, upholds the core-values of “Professional Quality and Technological Leadership.” The company specializes in developing AI-assisted screening technologies for breast ultrasound and lung CT, providing AI solutions for medical image analysis.
TaiHao’s AI technologies integrate smoothly with existing medical equipment, fully supporting the advancement of digital transformation and precision medicine. By working closely with clinical teams, we help healthcare providers adopt AI efficiently and apply it reliably in real-world practice. Our mission is to build a more accurate and efficient healthcare environment—and to be your trusted partner in Intelligent Healthcare.